Companies seeking investment from Archangels should contact our Investment Executive team to outline their business proposal and investment needs. Assuming that the basic Investment Criteria are met, then a business plan should be submitted to Archangels for review. This should include an overview of the company together with a brief financial summary outlining how much funding is being sought and how it will be used.
The Decision Process as to whether or not the syndicate wishes to progress an investment is designed to be as quick and helpful as possible. However, companies should be aware that Archangels will review over 100 proposals in any one year and will probably invest in around 2-3 (a normal investment profile).
Our Investment Philosophy reflects a patient approach to building good companies on solid foundations. We provide significant business experience as well as money and will continue to support good companies with follow-on rounds where appropriate. We have experience and skills at achieving sensible exits at the right time for both founders and investors.
Cable gets to grips with Great British design
25 Jun 2014MGB Biopharma Expands Scientific Advisory Board (SAB) with Medical Microbiologist Dr Stephanie Dancer
Business Secretary, Vince Cable, saw bionic limbs, an airship and a model of a hypersonic aircraft when he launched the ‘Pioneering Great British Products' report at Liverpool's Life Sciences University Technical College.
23 Jun 2014Touch Bionics founder receives Queen’s Honour
MGB Biopharma, a biopharmaceutical company developing truly novel anti-infectives, announces today that Dr Stephanie Dancer, an internationally renowned medical microbiologist, has joined its scientific advisory board (SAB). She will help oversee the development of MGB Biopharma’s lead antibiotic candidate, MGB-BP-3. An oral formulation of MGB-BP-3 is ready to enter Phase I development for Clostridium difficile, and an iv presentation is in late preclinical development for Gram-positive hospital acquired infections.
16 Jun 2014Touch Bionics introduces new control method for bionic hand
David Gow named Commander of the Order of the British Empire
Touch Bionics, a provider of world-leading prosthetic technologies, is proud to announce that the company's founder, David Gow, was named Commander of the Order of the British Empire (CBE) in this year's Queen's Birthday Honours list.
14 May 2014Technology Strategy Board Biomedical Catalyst Award to Drive Development of Novel System to Assess and Manage Tooth Decay (Dental Caries)
Livingston, Scotland – May 14, 2014 – Touch Bionics, a provider of world-leading prosthetic technologies, has announced the introduction of the latest enhancements to the i-limb™ ultra revolution at the OTWorld 2014 International Congress taking place in Leipzig, Germany.
09 May 2014
Calcivis, a medical devices company focused on revolutionising the management of tooth decay, today announces that it has received a prestigious Biomedical Catalyst award co-funding a £0.5m development programme and raised a further £0.8m in equity funding from existing investors Archangel Informal Investment and the Scottish Investment Bank, the investment arm of Scottish Enterprise.